- NEWS AND VIEWS
First encounter with SARS-CoV-2: immune portraits of COVID susceptibility
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-024-01644-x
References
Lindeboom, R. G. H. et al. Nature https://doi.org/10.1038/s41586-024-07575-x (2024).
Zhang, Q. et al. Science 370, eabd4570 (2020).
Bastard, P. et al. Science 370, eabd4585 (2020).
Monk, P. D. et al. ERJ Open Res. 9, 00605-02022 (2023).
Kalil, A. C. et al. Lancet Respir. Med. 9, 1365–1376 (2021).
Davoudi-Monfared, E. et al. Antimicrob. Agents Chemother. 64, e01061-20 (2020).
Policard, M., Jain, S., Rego, S. & Dakshanamurthy, S. Virus Res. 301, 198464 (2021).
Saichi, M. et al. Nature Cell Biol. 23, 538–551 (2021).
Rudy, G. B. & Lew, A. M. J. Immunol. 158, 2116–2125 (1997).
Rowe, J. R., Neme de Gimenez, M. H., Emler, C. A. & Sheehy, M. J. Hum. Immunol. 29, 256–262 (1990).
Pathi, A. et al. J. Rheumatol. 48, 985–991 (2021).
Hill-Burns, E. M., Factor, S. A., Zabetian, C. P., Thomson, G. & Payami, H. PLoS ONE 6, e27109 (2011).
Competing Interests
The authors declare no competing interests.